Biography:
Yanyu Qi,is an Associate Chief Physician in the Department of Oncology at the Affiliated Hospital of Southwest Jiaotong University. His primary research focus is on mechanisms of resistance to chemotherapy, targeted therapy, and immunotherapy in malignancies. Clinically, he specializes in optimizing radiotherapy and interventional techniques, as well as developing multidisciplinary diagnosis and treatment protocols, with the goal of improving therapeutic efficacy and patient outcomes. He has published multiple peer-reviewed papers in high-impact journals, including Phytomedicine,Frontiers in Cell and Developmental Biology and China Pharmacy.
Title : Bevacizumab versus anlotinib respectively combined with chemotherapy drug in the treatment of EGFR-TKI acquired resistant advanced lung adenocarcinoma